Irit Gordon, Ph.D.


  Tel Aviv, Israel
 ++972-3-303-9076
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 Download vCard

Current Time
01:55 PM

Dr. Irit Gordon is a Partner in the Life Sciences Group at Pearl Cohen’s Tel Aviv office. As a Patent Attorney, Irit has extensive experience drafting freedom-to-operate and clearance opinions, specializing in the areas of pharmaceuticals, chemistry, and biology. Her practice also includes patent drafting, worldwide patent prosecution, patent strategy planning and portfolio management. Irit handles patent oppositions in Israel in the areas of biotechnology and pharmaceuticals.

Prior to joining Pearl Cohen, Irit was a scientific researcher at Tel-Aviv University and at the Institute of Psychiatry in London, United Kingdom.

Publications

Speiser Z, Gordon I, Rehavi M, Gitter S. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. Eur J Pharmacol. 1991;195:75-83.

Gordon I, Rehavi M, Mintz M. Bilateral imbalance in striatal DA-uptake sites controls rotational behavior. Brain Res. 1994;646:207-10.

Gordon I, Weitzman R, Rehavi M. [3H] GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors. Life Sci. 1994;55:189-99.

Gordon I, Mintz M, Rosenne E, Rehavi M. Long-term effects of amygdaloid kindling on striatal dopaminergic terminals. Brain Res Bull. 1995;36(3);235-9.

Mintz M, Gordon I, Roz N, Rehavi M. The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats. Brain Res. 1994;668:239-42.

Gordon I, Weitzman R, Rehavi M. [3H]GBR 12935 labels mainly the piperazine acceptor site in rats prefrontal cortex. Brain Res. 1995;674(2):205-10.

Gordon I, Weitzman R, Rosenne E, Rehavi M. Developmental and age-related alternations in rat brain presynaptic dopaminergic mechanisms. Develop Brain Res. 1995;85(2):225-8.

Gordon I, Weitzman R, Rehavi M. Regulation of [3H]GBR 12935 binding sites by drugs. Eur J Pharmacol. 1996;298(1):27-30.

Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett. 1995;199:1-5.

Genis I, Gordon I, Sehayek E, Michaelson DM. Hyperphosphorylation of tau apolipoprotein E-deficient mice. Neurosci Lett. 1995;199:6-9.

Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. Biochemical and cognitive studies of apoE-deficient mice. Mol Chem Neuropathol. 1996;28(1-3):97-103.

Gordon I, Ben Eliyahu S, Rosenne E, Sehayek E, Michaelson DM. Derangement in stress response of apolipoprotein E-deficient mice. Neurosci Lett. 1996;206:212-4.

Gordon I, Abdulla EM, Campbell IC, Whatley SA. Phosmet induces up-regulation of surface levels of the cellular prion protein. Neuroreport. 1998;9(7):1391-5.